Holen Sie sich die Stockscreener-App
16.10
0.63%
0.10
Handel nachbörslich:
16.10
Schlusskurs vom Vortag:
$16.00
Offen:
$15.63
24-Stunden-Volumen:
805.57K
Relative Volume:
1.29
Marktkapitalisierung:
$2.07B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-151.09M
KGV:
-8.895
EPS:
-1.81
Netto-Cashflow:
$-160.51M
1W Leistung:
-3.77%
1M Leistung:
+0.31%
6M Leistung:
+81.51%
1J Leistung:
+128.69%
1-Tages-Spanne:
$15.00
$16.16
1-Wochen-Bereich:
$15.00
$18.74
52-Wochen-Spanne:
$5.583
$18.74
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile
Firmenname
Centessa Pharmaceuticals Plc Adr
Sektor
Branche
Telefon
44 7391 789784
Adresse
3RD FLOOR, ALTRINCHAM, CHESHIRE
Vergleichen Sie CNTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| CNTA | 16.10 | 2.07B | 0 | -151.09M | -160.51M | -1.81 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-03-17 | Eingeleitet | SVB Securities | Outperform |
| 2022-08-12 | Herabstufung | Morgan Stanley | Overweight → Underweight |
| 2022-06-17 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-06-03 | Herabstufung | Jefferies | Buy → Hold |
| 2022-02-11 | Eingeleitet | Goldman | Neutral |
Centessa Pharmaceuticals Plc Adr Aktie (CNTA) Neueste Nachrichten
Centessa Pharmaceuticals CEO sells shares worth $585,418 - Investing.com India
Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update - GlobeNewswire Inc.
Centessa Pharmaceuticals' chief business officer sells shares for $180,628 - Investing.com
Centessa Pharmaceuticals plcADR (CNTA) Price Target Increased by 14.58% to 11.22 - MSN
Centessa Pharmaceuticals CEO sells shares worth $863,727 - Investing.com
Centessa Pharmaceuticals plc ADR (CNTA) expanding its growth trajectory ahead - SETE News
GSK Plc ADR [GSK] Insider Activity: An Update for Investors - Knox Daily
Centessa Pharmaceuticals plc ADR (CNTA) Stock: Uncovering 52-Week Market Trends - The InvestChronicle
Analysts review Bilibili Inc ADR’s rating - Knox Daily
Centessa Pharmaceuticals plc ADR (CNTA) shows promising results - US Post News
Ratios Uncovered: Breaking Down Centessa Pharmaceuticals plc ADR (CNTA)’s Trailing Twelve Months Metrics - The Dwinnex
Centessa Pharmaceuticals executive sells over $260k in company stock - Investing.com India
Centessa Pharmaceuticals executive sells over $260k in company stock By Investing.com - Investing.com South Africa
Centessa Pharmaceuticals plc ADR [CNTA] Shares Rise 2.15 % on Thursday - Knox Daily
Centessa Pharmaceuticals plc ADR (CNTA) is looking forward to a strong quarter - SETE News
Centessa's ORX142 shows promise for treating daytime sleepiness - Investing.com India
Monitoring Accenture plc (ACN) after recent insider movements - Knox Daily
ALLE stock rated an Underweight by Barclays - Knox Daily
Understanding the Risks of Investing in BranchOut Food Inc (BOF) - Knox Daily
EON Resources Inc. [EONR] Investment Guide: What You Need to Know - Knox Daily
Analysts review Reneo Pharmaceuticals Inc’s rating - Knox Daily
Analyzing Pineapple Energy Inc (PEGY) After Recent Trading Activity - Knox Daily
Investing in nVent Electric plc (NVT): What You Must Know - Knox Daily
Peraso Inc’s latest rating changes from various analysts - Knox Daily
Fiserv, Inc. [FI] Insider Bisignano Frank sells 145,000 Shares – Latest Insider Activity - Knox Daily
The Attractiveness of Investing In GE Aerospace (GE) is Growing - Knox Daily
President and CEO, MADER MARK PATRICK sold 20,000 shares of Smartsheet Inc [SMAR] - Knox Daily
Henry Schein Inc. [HSIC] Insider McGlynn Lorelei sells 21,035 Shares – McGlynn Lorelei Activity - Knox Daily
A Guide To The Risks Of Investing In Autodesk Inc. (ADSK) - Knox Daily
Is it a good time to sell Xcel Energy, Inc. [XEL] shares after an insider sold 2,041 shares? - Knox Daily
Chief Executive Officer, Scots-Knight Denise sold 60,046 shares of Mereo Biopharma Group Plc ADR [MREO] - Knox Daily
Verona Pharma Plc ADR [VRNA] President and CEO makes an insider sale of 600,000 shares worth $2.25 million. - Knox Daily
Recent Insider Activity Could Benefit Tractor Supply Co. (TSCO) - Knox Daily
Examining the Potential Price Growth of Biomarin Pharmaceutical Inc. (BMRN) - Knox Daily
The Potential Rise in the Price of Ventas Inc (VTR) following insiders activity - Knox Daily
Monitoring Ultragenyx Pharmaceutical Inc. (RARE) after recent insider movements - Knox Daily
Investing in Cannae Holdings Inc (CNNE): What You Must Know - Knox Daily
Analysts review Dyne Therapeutics Inc’s rating - Knox Daily
Citigroup analysts initates a Buy rating for Crinetics Pharmaceuticals Inc (CRNX) - Knox Daily
Texas Roadhouse Inc [TXRH] Insider Jones Wayne L. sells 700 Shares – Insider Selling Alert - Knox Daily
The Potential Rise in the Price of TransUnion (TRU) following insiders activity - Knox Daily
An Analysis of Trane Technologies plc (TT)’s Potential Price Growth - Knox Daily
OneMain Holdings Inc (OMF) gets rating Initiated from BTIG Research - Knox Daily
Chipotle Mexican Grill [CMG] Investment Appeal on the Rise - Knox Daily
Macrogenics Inc (MGNX) may enjoy gains as insiders got busy in the recent days - Knox Daily
Investing in CareTrust REIT Inc (CTRE) Is Getting More Attractive - Knox Daily
TD Cowen’s latest rating for KBR stock - Knox Daily
Upwork Inc (UPWK) Becoming More Attractive for Investors - Knox Daily
Investing in Trio Petroleum Corp. (TPET) Is Getting More Attractive - Knox Daily
Everi Holdings Inc (EVRI) gets rating Resumed from B. Riley Securities - Knox Daily
Recent Insider Activity Could Benefit Janus Henderson Group plc (JHG) - Knox Daily
Finanzdaten der Centessa Pharmaceuticals Plc Adr-Aktie (CNTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):